SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCHETTI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.759
AS - Asia 7.444
EU - Europa 3.969
SA - Sud America 1.160
AF - Africa 167
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 26.517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.462
SG - Singapore 2.747
CN - Cina 1.937
BR - Brasile 912
VN - Vietnam 900
DE - Germania 891
UA - Ucraina 756
HK - Hong Kong 612
IT - Italia 495
TR - Turchia 458
GB - Regno Unito 409
FI - Finlandia 252
SE - Svezia 242
FR - Francia 239
RU - Federazione Russa 214
JP - Giappone 188
PL - Polonia 159
CA - Canada 141
IN - India 139
MX - Messico 123
BD - Bangladesh 94
AR - Argentina 86
ID - Indonesia 74
NL - Olanda 64
ZA - Sudafrica 62
IQ - Iraq 53
BE - Belgio 48
ES - Italia 46
EC - Ecuador 45
PK - Pakistan 37
CZ - Repubblica Ceca 34
MA - Marocco 30
UZ - Uzbekistan 30
CO - Colombia 29
VE - Venezuela 26
CL - Cile 22
LT - Lituania 21
PH - Filippine 21
SA - Arabia Saudita 21
KE - Kenya 18
MY - Malesia 18
PY - Paraguay 18
IE - Irlanda 15
TN - Tunisia 15
AT - Austria 14
NP - Nepal 13
IR - Iran 12
JO - Giordania 12
UY - Uruguay 12
TW - Taiwan 11
AU - Australia 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
PT - Portogallo 9
CR - Costa Rica 8
EG - Egitto 8
PE - Perù 8
RO - Romania 8
AL - Albania 6
AZ - Azerbaigian 6
CH - Svizzera 6
DZ - Algeria 6
JM - Giamaica 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
ET - Etiopia 5
OM - Oman 5
RS - Serbia 5
SN - Senegal 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
EU - Europa 4
GR - Grecia 4
LV - Lettonia 4
PA - Panama 4
DO - Repubblica Dominicana 3
HU - Ungheria 3
LB - Libano 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
EE - Estonia 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
LK - Sri Lanka 2
MK - Macedonia 2
MT - Malta 2
NI - Nicaragua 2
PR - Porto Rico 2
QA - Qatar 2
SI - Slovenia 2
Totale 26.492
Salva come PNG Salva come JPEG
Città #
Singapore 1.701
Ashburn 1.348
Fairfield 1.044
Woodbridge 1.044
San Jose 919
Chandler 780
Jacksonville 773
Houston 769
Ann Arbor 622
Santa Clara 605
Hong Kong 596
Beijing 565
Seattle 443
Wilmington 409
Cambridge 378
Dallas 346
Ho Chi Minh City 293
Izmir 259
Nanjing 244
New York 225
Munich 218
Hanoi 212
Los Angeles 211
Tokyo 181
Boardman 179
Princeton 171
Warsaw 150
Lauterbourg 143
The Dalles 139
Ferrara 136
San Diego 111
São Paulo 95
Buffalo 94
Milan 89
Mexico City 86
Shanghai 84
Orem 78
Council Bluffs 73
Nanchang 70
Shenyang 69
Dearborn 63
Bremen 62
Tianjin 62
London 58
Hebei 57
Helsinki 57
Turku 54
Hefei 52
Frankfurt am Main 46
Brussels 45
Düsseldorf 45
Montreal 45
San Mateo 45
Jakarta 44
Jiaxing 44
Changsha 43
Toronto 41
Chennai 40
Falkenstein 38
Falls Church 38
Da Nang 37
Haiphong 36
Chicago 35
Brooklyn 34
Jinan 34
Johannesburg 33
Moscow 33
Denver 32
Amsterdam 31
Kunming 31
Norwalk 29
Addison 28
Redwood City 28
Rio de Janeiro 28
Tashkent 28
Brno 27
Manchester 27
Belo Horizonte 26
San Francisco 26
Guangzhou 24
Rome 24
Stockholm 24
Atlanta 23
Baghdad 23
Auburn Hills 22
Boston 22
Des Moines 21
Nuremberg 21
Zhengzhou 20
Biên Hòa 19
Mountain View 19
Curitiba 18
Hải Dương 18
Augusta 16
Bắc Ninh 16
Hangzhou 16
Mumbai 16
Ningbo 16
Nairobi 15
Philadelphia 15
Totale 17.922
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 348
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 319
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 298
Hemostasis biomarkers in multiple sclerosis 255
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 251
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 249
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 249
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 246
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 246
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 246
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 244
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 242
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 241
Membrane binding and anticoagulant properties of protein S natural variants 238
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 236
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 228
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 226
c-myc oncogene alterations in human thyroid carcinomas. 220
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 218
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 214
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 213
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 207
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 205
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 205
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 205
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 201
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 200
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 198
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 196
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 195
Plasma levels of soluble NCAM in multiple sclerosis 194
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 191
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 191
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 191
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 190
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 189
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 189
Partial gene deletion in a family with factor X deficiency 188
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 188
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 187
alpha-Thalassemia trait in the region of Ferrara. 186
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 185
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 184
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 183
Factor VII mutant V154G models a zymogen-like form of factor VIIa 183
Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes 183
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 182
Molecular mechanisms of FVII deficiency: Expression of mutations clustered in the IVS7 donor splice site of factor VII gene 181
Calmodulin Is a Marker of a Distinct Smooth Muscle Cell Population Recruited by Plaque-Derived Macrophages from the Human Carotid Artery Media 178
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 177
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 176
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 176
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 175
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 175
CHROMOSOMAL LOCALIZATION AND CHARACTERIZATION OF RFLPs IN THE VON WILLEBRAND FACTOR PSEUDOGENE 175
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 175
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 174
Taqi polymorphism at the human coagulation factor XII locus (F12) 173
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 172
Two taqI RFLPs in the human von willebrand factor gene 168
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 167
Localization of cloned human DNA sequences and analysis of chromosomal alteration by in situ hybridization 166
Two additional TaqI RFLPs in von willebrand factor gene (VWF) and pseudogene 166
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 165
Detection and characterization of polymorphic markers in the factor-VII gene. 164
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 163
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 162
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 162
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 162
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 162
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 162
A HIND III RFLP AND A GENE LESION IN THE COAGULATION FACTOR-VIII GENE 161
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 160
Molecular genetics and biology of congenital hemorrhagic diseases 160
The Gly331Ser mutation in factor VII in Europe and the Middle East 159
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 159
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients 159
Sublocalization of von Willebrand Factor Pseudogene in 22q11.22-q11.23 and Detection of two TaqI RFLPs. 155
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 154
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 154
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 152
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 152
Alterazione genica "de novo" in una variante della malattia di von Willebrand. 152
Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation 152
Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma 151
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 151
Hemostasis gene expression of the internal jugular and saphenous veins 151
Risks factors for highly unstable response to oral anticoagulation: a case-control study 149
A FREQUENT FACTOR-XII GENE MUTATION IN HAGEMAN TRAIT 149
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 149
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 148
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 148
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 147
Non-conventional therapeutic strategies for inherited disorders of hemostasis 147
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 146
Decay of β-globin synthesis in heterozygous β 0 Ferrara thalassaemia 145
Clinical picture and management of congenital factor VII deficiency 145
PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A. 145
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 145
β+-thalassaemia in the Po river delta region (northern Italy): Genotype and β globin synthesis 142
Totale 18.686
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.050
Totale 115.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021434 0 0 0 0 0 0 0 0 0 0 313 121
2021/20221.826 115 191 130 111 114 64 73 80 53 129 153 613
2022/20231.766 189 123 45 215 282 289 74 165 221 14 91 58
2023/2024924 69 91 34 32 64 191 20 62 23 20 24 294
2024/20253.496 93 66 295 99 468 299 78 173 507 479 536 403
2025/20269.915 974 410 1.066 1.331 1.495 707 1.306 507 941 966 212 0
Totale 26.726